RHEOL® SNAC, chemically known as 8-(2-hydroxybenzamido)octanoic acid sodium salt, is a white to off-white crystalline solid with good water solubility. It is a high-performance oral permeation enhancer that locally elevates gastric pH, promotes peptide monomerization, and anchors absorption in the stomach to significantly improve oral bioavailability.
Item No :
RHEOL® SNACProduct Origin :
CHINAShipping Port :
SHANG HAIPayment :
TT/LCWeight :
20/25KGOrder(MOQ) :
100KG
RHEOL® SNAC is one of the most clinically validated oral absorption enhancers in the pharmaceutical industry, designed as a pharmaceutical excipient that adheres to the gastric mucosa alongside peptide actives. It creates a localized microenvironment that protects the drug from peptic degradation, drives peptide monomerization for enhanced permeability, inserts into the gastric epithelial cell membrane to enable transcellular transport, and anchors the absorption site in the stomach to maximize oral bioavailability. RHEOL® SNAC delivered by Westpoint offers formulation scientists a reliable enabling excipient for the next generation of oral peptide and macromolecule therapeutics.
The oral semaglutide (Rybelsus®) developed by Novo Nordisk is co-formulated with 300 mg of SNAC and 7 mg or 14 mg of semaglutide. Validated by the PIONEER 10 phase III clinical trials, its glucose-lowering and weight-loss effects are comparable to subcutaneous injection.
| Description | Maximum Single Impurity (%) | Total Impurities (%) |
|---|---|---|
| White to pale yellow or slightly pink powder | ≤ 0.1 | ≤ 1.0 |